Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83


Cancer stem cells in pancreatic cancer.

Bao Q, Zhao Y, Renner A, Niess H, Seeliger H, Jauch KW, Bruns CJ.

Cancers (Basel). 2010 Aug 19;2(3):1629-41. doi: 10.3390/cancers2031629.


A concise review on the current understanding of pancreatic cancer stem cells.

Vaz AP, Ponnusamy MP, Seshacharyulu P, Batra SK.

J Cancer Stem Cell Res. 2014;2. pii: e1004.


New insights into pancreatic cancer stem cells.

Rao CV, Mohammed A.

World J Stem Cells. 2015 Apr 26;7(3):547-55. doi: 10.4252/wjsc.v7.i3.547. Review.


Cancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.

Tanase CP, Neagu AI, Necula LG, Mambet C, Enciu AM, Calenic B, Cruceru ML, Albulescu R.

World J Gastroenterol. 2014 Aug 21;20(31):10790-801. doi: 10.3748/wjg.v20.i31.10790. Review.


Overcoming chemo/radio-resistance of pancreatic cancer by inhibiting STAT3 signaling.

Wu X, Tang W, Marquez RT, Li K, Highfill CA, He F, Lian J, Lin J, Fuchs JR, Ji M, Li L, Xu L.

Oncotarget. 2016 Mar 8;7(10):11708-23. doi: 10.18632/oncotarget.7336.


Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study.

Wang MC, Jiao M, Wu T, Jing L, Cui J, Guo H, Tian T, Ruan ZP, Wei YC, Jiang LL, Sun HF, Huang LX, Nan KJ, Li CL.

Oncotarget. 2016 Feb 23;7(8):9586-99. doi: 10.18632/oncotarget.7078.


Pancreatic cancer stem cells: new insight into a stubborn disease.

Zhan HX, Xu JW, Wu D, Zhang TP, Hu SY.

Cancer Lett. 2015 Feb 28;357(2):429-37. doi: 10.1016/j.canlet.2014.12.004. Epub 2014 Dec 8. Review.


Pancreatic cancer stem cells.

Lee CJ, Dosch J, Simeone DM.

J Clin Oncol. 2008 Jun 10;26(17):2806-12. doi: 10.1200/JCO.2008.16.6702. Review.


Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy.

Bao B, Ahmad A, Azmi AS, Ali S, Sarkar FH.

Curr Protoc Pharmacol. 2013 Jun;Chapter 14:Unit 14.25. doi: 10.1002/0471141755.ph1425s61. Review.


A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.

Rajeshkumar NV, Rasheed ZA, García-García E, López-Ríos F, Fujiwara K, Matsui WH, Hidalgo M.

Mol Cancer Ther. 2010 Sep;9(9):2582-92. doi: 10.1158/1535-7163.MCT-10-0370. Epub 2010 Jul 26.


Targeting epigenetic regulation of miR-34a for treatment of pancreatic cancer by inhibition of pancreatic cancer stem cells.

Nalls D, Tang SN, Rodova M, Srivastava RK, Shankar S.

PLoS One. 2011;6(8):e24099. doi: 10.1371/journal.pone.0024099. Epub 2011 Aug 31.


Secretome protein signature of human pancreatic cancer stem-like cells.

Brandi J, Dalla Pozza E, Dando I, Biondani G, Robotti E, Jenkins R, Elliott V, Park K, Marengo E, Costello E, Scarpa A, Palmieri M, Cecconi D.

J Proteomics. 2016 Mar 16;136:1-12. doi: 10.1016/j.jprot.2016.01.017. Epub 2016 Feb 2.


Cancer stem cell in the progression and therapy of pancreatic cancer.

Xu L.

Front Biosci (Landmark Ed). 2013 Jun 1;18:795-802. Review.


Stem cells, colorectal cancer and cancer stem cell markers correlations.

Cherciu I, Bărbălan A, Pirici D, Mărgăritescu C, Săftoiu A.

Curr Health Sci J. 2014 Jul-Sep;40(3):153-61. doi: 10.12865/CHSJ.40.03.01. Epub 2014 Aug 4. Review.


Pancreatic cancer stem-like cells display aggressive behavior mediated via activation of FoxQ1.

Bao B, Azmi AS, Aboukameel A, Ahmad A, Bolling-Fischer A, Sethi S, Ali S, Li Y, Kong D, Banerjee S, Back J, Sarkar FH.

J Biol Chem. 2014 May 23;289(21):14520-33. doi: 10.1074/jbc.M113.532887. Epub 2014 Apr 9.


The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness.

Bao B, Azmi AS, Ali S, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH.

Biochim Biophys Acta. 2012 Dec;1826(2):272-96. doi: 10.1016/j.bbcan.2012.04.008. Epub 2012 May 10. Review.


Cancer stem cells and their potential implications for the treatment of solid tumors.

Grotenhuis BA, Wijnhoven BP, van Lanschot JJ.

J Surg Oncol. 2012 Aug 1;106(2):209-15. doi: 10.1002/jso.23069. Epub 2012 Feb 27. Review.


Targeting notch to eradicate pancreatic cancer stem cells for cancer therapy.

Wang Z, Ahmad A, Li Y, Azmi AS, Miele L, Sarkar FH.

Anticancer Res. 2011 Apr;31(4):1105-13. Review.


Pancreatic cancer stem cells: regulatory networks in the tumor microenvironment and targeted therapy.

Takao S, Ding Q, Matsubara S.

J Hepatobiliary Pancreat Sci. 2012 Nov;19(6):614-20. doi: 10.1007/s00534-012-0547-1. Review.


Bulk pancreatic cancer cells can convert into cancer stem cells(CSCs) in vitro and 2 compounds can target these CSCs.

Ning X, Du Y, Ben Q, Huang L, He X, Gong Y, Gao J, Wu H, Man X, Jin J, Xu M, Li Z.

Cell Cycle. 2016;15(3):403-12. doi: 10.1080/15384101.2015.1127471.

Supplemental Content

Support Center